| Literature DB >> 19965856 |
Esteban A Fridman1, Marcos Crespo, Santiago Gomez Argüello, Lorena Degue, Mirta Villarreal, Stephan Bohlhalter, Lewis Wheaton, Mark Hallett.
Abstract
Background Focal spasticity is a significant motor disorder following stroke, and Botulinum Toxin Type-A (BoNT-A) is a useful treatment for this. The authors evaluated kinematic modifications induced by spasticity, and whether or not there is any improvement following injection of BoNT-A. Methods Eight patients with stroke with upper-limb spasticity, showing a flexor pattern, were evaluated using kinematics before and after focal treatment with BoNT-A. A group of sex- and age-matched normal volunteers acted as a control group. Results Repeated-measures ANOVA showed that patients with stroke performed more slowly than the control group. Following treatment with BoNT-A, there was a significant improvement in kinematics in patients with stroke, while in the control group, performance remained unchanged. Conclusions Focal treatment of spasticity with BoNT-A leads to an adaptive change in the upper limb of patients with spastic stroke.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19965856 PMCID: PMC3163597 DOI: 10.1136/jnnp.2009.188052
Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN: 0022-3050 Impact factor: 10.154